Insurance News & Info

WEDNESDAY, Feb. 1 (HealthDay News) — New research suggests that it may be safe to give the clot-busting drug tPA to people who wake up with stroke symptoms, even though there is a short time window in which to use the treatment and doctors have n… View full post on Yahoo! Health News

WEDNESDAY, Feb. 1 (HealthDay News) — An investigational drug called apixaban (Eliquis) appears to be better than aspirin at preventing blood clots in certain patients who have already suffered a stroke or so-called "mini-stroke" due to … View full post on Yahoo! Health News

WASHINGTON (Reuters) – Regulators approved Vertex Pharmaceuticals' Kalydeco, the first drug designed to treat the underlying cause of cystic fibrosis. The Food and Drug Administration said on Tuesday Kalydeco was effective in treating people w… View full post on Yahoo! Health News

(Reuters) – U.S. health regulators on Monday approved Roche's pill to treat an advanced form of the most common form of skin cancer, known as basal cell carcinoma. The drug, Erivedge, which was co-developed by Curis Inc, was given a green ligh… View full post on Yahoo! Health News

MONDAY, Jan. 30 (HealthDay News) — The U.S. Food and Drug Administration on Monday approved a drug to treat the most common form of skin cancer, basal cell carcinoma. View full post on Yahoo! Health News

Key players in the pharmaceutical industry pledged on Monday to donate 14 billion drug treatments as part of a new, global push to eradicate tropical diseases. View full post on Yahoo! Health News

MONDAY, Jan. 30 (HealthDay News) — A dramatic rise in newborns experiencing drug withdrawal after being exposed in the womb poses challenges for clinicians on how to detox these tiny victims, a new report indicates. View full post on Yahoo! Health News

(Reuters) – Cell Therapeutics Inc said on Monday it has voluntarily withdrawn the marketing application for its cancer drug, sending its shares down 17 percent before the bell. The company said it withdrew the application as it needed additional t… View full post on Yahoo! Health News

LONDON (Reuters) – British pharmaceutical firm BTG said the first of two U.S. trials of its varicose vein treatment Varisolve had met all its end-points, bringing a launch of the long-delayed product a step closer. Varisolve is a ground-breaking t… View full post on Yahoo! Health News

WASHINGTON (Reuters) – Amylin Pharmaceuticals won U.S. approval on Friday for its Bydureon diabetes drug, a long-awaited victory for the company's most promising product. After two delays, the Food and Drug Administration approved once-weekly … View full post on Yahoo! Health News